These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17688499)

  • 41. Testing homogeneity of two zero-inflated Poisson populations.
    Tse SK; Chow SC; Lu Q; Cosmatos D
    Biom J; 2009 Feb; 51(1):159-70. PubMed ID: 19219907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calculating sample size for studies with expected all-or-none nonadherence and selection bias.
    Shardell MD; El-Kamary SS
    Biometrics; 2009 Jun; 65(2):635-9. PubMed ID: 18759830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tests for inter-subject and total variabilities under crossover designs.
    Lee Y; Shao J; Chow SC; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness.
    Gould AL; Koglin J; Bain RP; Pinto CA; Mitchel YB; Pasternak RC; Sapre A
    Clin Trials; 2009 Aug; 6(4):305-19. PubMed ID: 19667027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous toxicity monitoring in phase II trials in oncology.
    Ivanova A; Qaqish BF; Schell MJ
    Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small-sample performance of the robust score test and its modifications in generalized estimating equations.
    Guo X; Pan W; Connett JE; Hannan PJ; French SA
    Stat Med; 2005 Nov; 24(22):3479-95. PubMed ID: 15977302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression analysis of panel count data with dependent observation times.
    Sun J; Tong X; He X
    Biometrics; 2007 Dec; 63(4):1053-9. PubMed ID: 18078478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
    Friede T; Schmidli H
    Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sample size calculations for clinical studies allowing for uncertainty about the variance.
    Julious SA; Owen RJ
    Pharm Stat; 2006; 5(1):29-37. PubMed ID: 17080926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.
    Sahai H; Khurshid A
    Stat Med; 1996 Jan; 15(1):1-21. PubMed ID: 8614740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The perils with the misuse of predictive power.
    Dallow N; Fina P
    Pharm Stat; 2011; 10(4):311-7. PubMed ID: 20967762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sample size calculation for comparing two negative binomial rates.
    Zhu H; Lakkis H
    Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?
    Baker SG; Kramer BS; Corle D
    BMC Med Res Methodol; 2004 Oct; 4():24. PubMed ID: 15461821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.